Electronic cigarettes for smoking cessation

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 9, 2016, Pages

  Hartmann Boyce, Jamie ^a   Mcrobbie, Hayden ^b   Bullen, Chris ^c   Begh, Rachna ^a   Stead, Lindsay F ^a   Hajek, Peter ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; NICOTINE;

ASTHMA; BLOOD LEVEL; CARBON MONOXIDE BLOOD LEVEL; COHORT ANALYSIS; COUGHING; DIZZINESS; DRY THROAT; DYSPNEA; ELECTRONIC CIGARETTE; FOLLOW UP; HEADACHE; HEART DISEASE; HEART RATE; HUMAN; INTERVENTION STUDY; META ANALYSIS; MOUTH DISEASE; NAUSEA; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIDE EFFECT; SMOKING CESSATION; STOMACH DISEASE; SYSTEMATIC REVIEW; THROAT IRRITATION; WITHDRAWAL SYNDROME; XEROSTOMIA;

EID: 84987700907     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010216.pub3     Document Type: Review

References (198)

1. Adriaens K, Van Gucht D, Declerck P, Baeyens F. Effectiveness of the electronic cigarette: An eight-week Flemish study with six-month follow-up on smoking reduction, craving and experienced benefits and complaints. International Journal of Environmental Research and Public Health 2014;11(11):11220-48.
2. Al-Delaimy WK, Myers MG, Leas EC, Strong DR, Hofstetter CR. E-cigarette use in the past and quitting behavior in the future: a population-based study. American Journal of Public Health 2015;105(6):1213-9.
3. Donzelli A. E-cigarettes may impair ability to quit, but other explanations are possible. American Journal of Public Health 2015;105(11):e1.
4. Barton MK. Electronic cigarettes did not help patients with cancer stop smoking. CA: a cancer journal for clinicians 2015;65(2):85-6.
5. Borderud SP, Li Y, Burkhalter JE, Sheffer CE, Ostroff JS. Electronic cigarette use among patients with cancer: characteristics of electronic cigarette users and their smoking cessation outcomes. Cancer 2014;120(22):3527-35.
6. Fillon M. Electronic cigarettes might not help cancer patients quit smoking. Journal of the National Cancer Institute 2015;107(1):496.
7. Brose LS, Hitchman SC, Brown J, West R, McNeill A. Is the use of electronic cigarettes while smoking associated with smoking cessation attempts, cessation and reduced cigarette consumption? A survey with a 1-year follow-up. Addiction 2015;110(7):1160-8.
8. Brown J, West R, Beard E, Michie S, Shahab L, McNeill A. Prevalence and characteristics of e-cigarette users in Great Britain: Findings from a general population survey of smokers. Addictive Behaviors 2014;39(6):1120-5.
9. Hitchman SC, Brose LS, Brown J, Robson D, McNeill A. Associations between e-cigarette type, frequency of use, and quitting smoking: findings from a longitudinal online panel survey in Great Britain. Nicotine & Tobacco Research 2015;17(10):1187-94.
10. Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J. Do electronic cigarettes help smokers quit? Results from a randomised controlled trial [Abstract]. European Respiratory Society Annual Congress, 2013 September 7 - 11, Barcelona, Spain 2013;42:215s-[P1047].
11. Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, et al. Electronic cigarettes and smoking cessation: a quandary? - Authors' reply. Lancet 2014;383(9915):408-9.
12. Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 2013;382(9905):1629-37.
13. Bullen C, Williman J, Howe C, Laugesen M, McRobbie H, Parag V, et al. Study protocol for a randomised controlled trial of electronic cigarettes versus nicotine patch for smoking cessation. BMC Public Health 2013;13:210.
14. O'Brien B, Knight-West O, Walker N, Parag V, Bullen C. E-cigarettes versus NRT for smoking reduction or cessation in people with mental illness: Secondary analysis of data from the ASCEND trial. Tobacco Induced Diseases 2014; Vol. 13, issue 1:5.
15. Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C, et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PloS One 2013;8(6):e66317.
16. Russo C, Cibella F, Caponnetto P, Campagna D, Maglia M, Frazzetto E, et al. Evaluation of post cessation weight gain in a 1-year randomized smoking cessation trial of electronic cigarettes. Scientific Reports 2016;6:18763.
17. Caponnetto P, Auditore R, Russo C, Cappello GC, Polosa R. Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. International Journal of Environmental Research and Public Health 2013;10(2):446-61.
18. Minutolo G, Caponnetto P, Auditore R, Russo C, Polosa R. Management of smoking reduction and cessation in inpatients with schizophrenia: Impact of electronic cigarettes. European Neuropsychopharmacology 2013;23:S581-2.
19. Choi K, Forster JL. Beliefs and experimentation with electronic cigarettes : a prospective analysis among young adults. American Journal of Preventive Medicine 2014;6(2):175-8.
20. Choi K. Forster JL. Authors' Response to: Context on use is needed before public health recommendations are made about e-cigarettes. Americal Journal of Preventive Medicine 2014;46(6):e58-59.
21. Ely J. Evaluation of the use of electric cigarettes in a rural smoking cessation program. Available online at: digitalunc.coalliance.org/fedora/repository/cogru:4161 2013 (accessed 1st November 2014).
22. Etter JF, Bullen C. A longitudinal study of electronic cigarette users. Addictive Behaviors 2014;39(2):491-4.
23. Grana RA, Popova L, Ling PM. A longitudinal analysis of electronic cigarette use and smoking cessation. JAMA Internal Medicine 2014;174(5):812-3.
24. Hajek P, Corbin L, Ladmore D, Spearing E. Adding e-cigarettes to specialist stop-smoking treatment: City of London pilot project. Journal of Addiction Research & Therapy 2015;6(244):(online ahead of print). [DOI: 10.4172/2155-6105.1000244]
25. Humair J-P, Tango R. Can e-cigarette help patients to reduce or stop smoking in primary care practice?. Journal of General Internal Medicine 2014;29:S480.
26. Manzoli L, Flacco ME, Fiore M, La Vecchia C, Marzuillo C, Gualano MR, et al. Electronic cigarettes efficacy and safety at 12 months: cohort study. PLoS One 2015;10(6):e0129443-
27. Manzoli L, La Vecchia C, Flacco ME, Capasso L, Simonetti V, Boccia S, et al. Multicentric cohort study on the long-term efficacy and safety of electronic cigarettes: study design and methodology. BMC public health 2013;13(1):883.
28. McRobbie H, Goniewicz M, Phillips A, Myers-Smith K, West O, Hajek P. Effects of the use of electronic cigarettes with and without concurrent smoking on acrolein delivery POS4-33. Society for Research on Nicotine and Tobacco, 20th Annual Meeting, Seattle, Washington. 2014:13. [www.srnt.org/conferences/2014/pdf/SRNT_2014_Rapids_C.pdf]
29. McRobbie H, Phillips A, Goniewicz ML, Smith KM, Knight-West O, Przulj D, et al. Effects of switching to electronic ccigarettes with and without concurrent smoking on exposure to nicotine, carbon monoxide, and acrolein. Cancer Prevention Research (Philadelphia, Pa.) 2015;8(9):873-8.
30. Nides MA, Leischow SJ, Bhatter M, Simmons M. Nicotine blood levels and short-term smoking reduction with an electronic nicotine delivery system. American Journal of Health Behavior 2014;38(2):265-74.
31. Oncken CA, Litt MD, McLaughlin LD, Burki NA. Nicotine concentrations with electronic cigarette use: effects of sex and flavor. Nicotine & Tobacco Research 2015;17(4):473-8.
32. Swedeh MA, Oncken C, Burki NK. Acute effects of electronic cigarettes on airway function in human subjects. American Thoracic Society International Conference Abstracts 2014;189:A4089.
33. Pacifici R, Pichini S, Graziano S, Pellegrini M, Massaro G, Beatrice F. Successful nicotine intake in medical assisted use of e-cigarettes: a pilot study. International Journal of Environmental Research and Public Health 2015;12(7):7638-46.
34. Polosa R, Caponnetto P, Morjaria JB, Papale G, Campagna D, Russo C. Effect of an electronic nicotine delivery device (e-cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health 2011;11:786.
35. Polosa R, Morjaria JB, Caponnetto P, Campagna D, Russo C, Alamo A, et al. Effectiveness and tolerability of electronic cigarette in real-life: a 24-month prospective observational study. Internal and Emergency Medicine 2014;9(5):537-46.
36. Polosa R, Morjaria J, Caponnetto P, Caruso M, Strano S, Battaglia E, et al. Effect of smoking abstinence and reduction in asthmatic smokers switching to electronic cigarettes: evidence for harm reversal. International Journal of Environmental Research & Public Health 2014;11(5):4965-77.
37. Polosa R, Caponnetto P, Maglia M, Morjaria JB, Russo C. Success rates with nicotine personal vaporizers: a prospective 6-month pilot study of smokers not intending to quit. BMC Public Health 2014;14:1159.
38. Polosa R, Caponnetto P, Cibella F, Le-Houezec J. Quit and smoking reduction rates in vape shop consumers: A prospective 12-month survey. International Journal of Environmental Research and Public Health 2015;12(4):3428-38.
39. Prochaska JJ, Grana RA. E-cigarette use among smokers with serious mental illness. PLoS One 2014;9(11):e113013.
40. Van Staden SR, Groenewald M, Engelbrecht R, Becker PJ, Hazelhurst LT. Carboxyhaemoglobin levels, health and lifestyle perceptions in smokers converting from tobacco cigarettes to electronic cigarettes. South African Medical Journal 2013;103(11):865-8.
41. Adkison SE, O'Connor RJ, Bansal-Travers M, Hyland A, Borland R, Yong HH, et al. Electronic nicotine delivery systems: international tobacco control four-country survey. American Journal of Preventive Medicine 2013;44(3):207-15.
42. Battista L, Di Iorio M, Tancredi M, Acconcia MC, Torromeo C, Barilla F, et al. Cardiovascular effects of electronic cigarettes. Circulation 2013;128:A16755.
43. Biener L, Hargraves JL. A longitudinal study of electronic cigarette use among a population-based sample of adult smokers: Association with smoking cessation and motivation to quit. Nicotine & Tobacco Research 2015;17(2):127-33.
44. Brown J, Beard E, Kotz D, Michie S, West R. Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction 2014;109(9):1531-40.
45. Bullen C, McRobbie H, Thornley S, Glover M, Lin R, Laugesen M. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tobacco Control 2010;19(2):98-103.
46. Chausse P, Naughton G, Dutheil F. Electronic cigarettes: the resistance value of the heating filament could be the key to lung toxicity. Chest 2015;148(1):e29-30.
47. Chorti M, Poulianiti K, Jamurtas A, Kostikas K, Tzatzarakis M, Vynias D, et al. Effects of active and passive electronic and tobacco cigarette smoking on lung function (P08-02). Toxicology Letters 2012;211:S64.
48. Czogala J, Cholewinski M, Kutek A, Zielinska-Danch W. [Evaluation of changes in hemodynamic parameters after the use of electronic nicotine delivery systems among regular cigarette smokers]. [Polish]. Przeglad lekarski 2012;69(10):841-5.
49. Dawkins L, Turner J, Hasna S, Soar K. The electronic-cigarette: effects on desire to smoke, withdrawal symptoms and cognition. Addictive Behaviors 2012;37(8):970-3.
50. Dawkins L, Turner J, Crowe E. Nicotine derived from the electronic cigarette improves time-based prospective memory in abstinent smokers. Psychopharmacology 2013;227(3):377-84.
51. Dawkins L, Corcoran O. Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacology 2014;231(2):401-7.
52. Douptcheva N, Gmel G, Studer J, Deline S, Etter JF. Use of electronic cigarettes among young Swiss men. Journal of Epidemiology & Community Health 2013;67(12):1075-6.
53. Dutra LM, Glantz SA. Electronic cigarettes and conventional cigarette use among U.S. adolescents: a cross-sectional study. JAMA Pediatrics 2014;168(7):610-7.
54. Eissenberg T. Electronic nicotine delivery devices: ineffective nicotine delivery and craving suppression after acute administration. Tobacco Control 2010;19(1):87-8.
55. Farsalinos K, Tsiapras D, Kyrzopoulos S, Savvopoulou M, Avramidou E, Vasilopoulou D, et al. Acute effects of using an electronic nicotine-delivery device (e-cigarette) on myocardial function: comparison with the effects of regular cigarettes. European Heart Journal 2012;33:203.
56. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V. Acute effects of using an electronic nicotine-delivery device (electronic cigarette) on myocardial function: comparison with the effects of regular cigarettes. BMC Cardiovascular Disorders 2014;14:78.
57. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V. Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of "vapers" who had achieved complete substitution of smoking. Substance Abuse: Research and Treatment 2013;7:139-46.
58. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Spyrou A, Voudris V. Impact of flavour variability on electronic cigarette use experience: an internet survey. International Journal of Environmental Research & Public Health 2013;10(12):7272-82.
59. Farsalinos K, Tsiapras D, Kyrzopoulos S, Stefopoulos C, Spyrou A, Tsakalou M, et al. Immediate effects of electronic cigarette use on coronary circulation and blood carboxyhemoglobin levels: comparison with cigarette smoking. European Heart Journal 2013;34(Suppl 1):13.
60. Farsalinos K, Tsiapras D, Kyrzopoulos S, Spyrou A, Stefopoulos C, Romagna G, et al. Effects of electronic cigarette use on the elastic properties of the ascending aorta in healthy subjects: comparison with the effects of tobacco cigarettes. European Heart Journal Cardiovascular Imaging 2013;14(Suppl 2):ii203.
61. Flouris AD, Poulianiti KP, Chorti MS, Jamurtas AZ, Kouretas D, Owolabi EO, et al. Acute effects of electronic and tobacco cigarette smoking on complete blood count. Food and Chemical Toxicology 2012;50(10):3600-3.
62. Flouris AD, Chorti MS, Poulianiti KP, Jamurtas AZ, Kostikas K, Tzatzarakis MN, et al. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhalation Toxicology 2013;25(2):91-101.
63. Gmel G, Baggio S, Mohler-Kuo M, Daeppen JB, Studer J. E-cigarette use in young Swiss men: is vaping an effective way of reducing or quitting smoking?. Swiss Medical Weekly 2016;146:w14271.
64. James SA, Meier EM, Wagener TL, Smith KM, Neas BR, Beebe LA. E-Cigarettes for immediate smoking substitution in women diagnosed with cervical dysplasia and associated disorders. International Journal of Environmental Health Research 2016;13(3):E288. [DOI: 10.3390/ijerph13030288]
65. NCT01842828 E-Cigarettes as an addition to multi-component treatment for tobacco dependence: a pilot study. clinicaltrials.gov/show/NCT01842828 (accessed 16 July 2014).
66. Kasza KA, Bansal-Travers M, O'Connor RJ, Compton WM, Kettermann A, Borek N, et al. Cigarette smokers' use of unconventional tobacco products and associations with quitting activity: findings from the ITC-4 U.S. cohort. Nicotine & Tobacco Research 2013;16(6):672-81.
67. Kouretas D, Poulianiti K, Chorti M, Jamurtas A, Kostikas K, Tzatzarakis M, et al. Effects of electronic cigarette and tobacco cigarette smoking on complete blood count (P08-03). Toxicology Letters 2012;211:S64.
68. Lee S, Grana RA, Glantz SA. Electronic cigarette use among Korean adolescents: a cross-sectional study of market penetration, dual use, and relationship to quit attempts and former smoking. Journal of Adolescent Health 2014;54(6):684-90.
69. Marini S, Buonanno G, Stabile L, Ficco G. Short-term effects of electronic and tobacco cigarettes on exhaled nitric oxide. Toxicology and Applied Pharmacology 2014;278(1):9-15.
70. Miura N, Yuki D, Minami N, Kakehi A, Futama Y. A study to investigate changes in the levels of biomarkers of exposure to selected cigarette smoke constituents in Japanese adult male smokers who switched to a non-combustion inhaler type of tobacco product. Regulatory Toxicology and Pharmacology 2015;71(3):498-506.
71. Palamidas A, Gennimata SA, Kaltsakas G, Tsikrika S, Vakali S, Gratziou C, et al. Acute effect of an e-cigarette with and without nicotine on lung function. Tobacco Induced Diseases 2014;12(Suppl 1):A34.
72. Pearson JL, Richardson A, Niaura RS, Vallone DM, Abrams DB. e-Cigarette awareness, use, and harm perceptions in US adults. American Journal of Public Health 2012;102(9):1758-66.
73. Pokhrel P, Fagan P, Little MA, Kawamoto CT, Herzog TA. Smokers who try e-cigarettes to quit smoking: findings from a multiethnic study in Hawaii. American Journal of Public Health 2013;103(9):e57-62.
74. Ling PM, Popova L. Novel "Tobacco" product use and association with smoking cessation: A national study. Journal of General Internal Medicine 2012;27(2 Suppl):S254.
75. Popova L, Ling PM. Alternative tobacco product use and smoking cessation: a national study. American Journal of Public Health 2013;103(5):923-30.
76. Schober W, Szendrei K, Matzen W, Osiander-Fuchs H, Heitmann D, Schettgen T, et al. Use of electronic cigarettes (e-cigarettes) impairs indoor air quality and increases FeNO levels of e-cigarette consumers. International Journal of Hygiene and Environmental Health 2014;217(6):628-37.
77. Siegel MB, Tanwar KL, Wood KS. Electronic cigarettes as a smoking-cessation tool: results from an online survey. American Journal of Preventive Medicine 2011;40(4):472-5.
78. Tsikrika S, Vakali S, Gennimata SA, Palamidas A, Kaltsakas G, Koulouris N, et al. Short term use of an e-cig: influence on clinical symptoms, vital signs and eCO levels. Tobacco Induced Diseases 2014;12(Suppl 1):A30.
79. Tzatzarakis MN, Tsitoglou KI, Chorti MS, Poulianiti KP, Jamurtas AZ, Koutedakis Y, et al. Acute and short term impact of active and passive tobacco and electronic cigarette smoking on inflammatory markers. Toxicology Letters 2013;221(Suppl):S86.
80. Vakali S, Tsikrika S, Gennimata SA, Kaltsakas G, Palamidas A, Koulouris N, et al. E-Cigarette acute effect on symptoms and airway inflammation: comparison of nicotine with a non-nicotine cigarette. Tobacco Induced Diseases 2014;12(Suppl 1):A35.
81. Vansickel AR, Cobb CO, Weaver MF, Eissenberg TE. A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiology, Biomarkers & Prevention 2010;19(8):1945-53.
82. Vansickel AR, Weaver MF, Eissenberg T. Clinical laboratory assessment of the abuse liability of an electronic cigarette. Addiction 2012;107(8):1493-500.
83. Vansickel AR, Eissenberg T. Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine & Tobacco Research 2013;15(1):267-70.
84. Vardavas CI, Anagnostopoulos N, Kougias M, Evangelopoulou V, Connolly GN, Behrakis PK. Short-term pulmonary effects of using an electronic cigarette: Impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest 2012;141(6):1400-6.
85. Vickerman KA, Carpenter KM, Altman T, Nash CM, Zbikowski SM. Use of electronic cigarettes among state tobacco cessation quitline callers. Nicotine & Tobacco Research 2013;15(10):1787-91.
86. Wagener TL, Meier E, Hale JJ, Oliver ER, Warner ML, Driskill LM, et al. Pilot investigation of changes in readiness and confidence to quit smoking after E-cigarette experimentation and 1 week of use. Nicotine & Tobacco Research 2014;16(1):108-14.
87. Walele T, Sharma G, Savioz R, Martin C, Williams J. A randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part A: Pharmacokinetics. Regulatory Toxicity 2016;74:187-92.
88. Walele T, Sharma G, Savioz R, Martin C, Williams J. A randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part B: Safety and subjective effects. Regulatory Toxicity 2016;74:193-9.
89. Yan XS, D'Ruiz C. Effects of using electronic cigarettes on nicotine delivery and cardiovascular function in comparison with regular cigarettes. Regulatory Toxicology and Pharmacology 2015;71(1):24-34.
90. Caponnetto P, Polosa R, Auditore R, Minutolo G, Signorelli M, Maglia M, et al. Smoking cessation and reduction in schizophrenia (SCARIS) with e-cigarette: study protocol for a randomized control trial. Trials [electronic resource] 2014;15:88.
91. NCT01979796 Antismoking effects of rlectronic cigarettes in subjects with schizophrenia and their potential influence on cognitive functioning: design of a randomized trial. Smoking Cessation And Reduction In Schizophrenia (The SCARIS Study). clinicaltrials.gov/show/NCT01979796 (accessed 16 July 2014).
92. ACTRN12612001210864 An open-label randomised pragmatic policy trial examining effectiveness of short-term use of Nicotine Replacement Therapy (NRT) vs short- or long-term use of NRT vs short- or long-term use of NRT or electronic nicotine delivery systems for smoking cessation in cigarette smokers. ACTRN12612001210864 (accessed 15 August 2016).
93. Fraser D, Borland R, Gartner C. Protocol for a randomised pragmatic policy trial of nicotine products for quitting or long-term substitution in smokers. BMC Public Health 2015;15:1026.
94. ISRCTN60477608 The efficacy of e-cigarettes compared with nicotine replacement therapy, when used within the UK stop smoking service. ISRCTN60477608 2014 (accessed 15 August 2016).
95. KCT0001277 Effect of an electronic cigarette for smoking reduction and cessation in Korean male smokers: a randomized, controlled study. KCT0001277 2014 (accessed 15 August 2016).
96. Lopez AA, Cobb CO, Yingst JM, Veldheer S, Hrabovsky S, Yen MS, et al. A transdisciplinary model to inform randomized clinical trial methods for electronic cigarette evaluation. BMC Public Health 2016;16(1):217. [CRS: 9400131000005107; PMCID:: PMC4778292; PUBMED: 26941050]
97. NCT02342795 Randomized controlled trial methods for novel tobacco products evaluation. clinicaltrials.gov/show/NCT02342795 (accessed 17 February 2016). [CRS: 9400131000005070;]
98. Lucchiari C, Masiero M, Veronesi G, Maisonneuve P, Spina S, Jemos C, et al. Benefits of e-cigarettes among heavy smokers undergoing a lung cancer screening program: randomized controlled trial protocol. JMIR Research Protocols 2016;5(1):e21. [CRS: 9400131000006459; PUBMED: 26842790]
99. NCT02422914 Benefits of tobacco free cigarette among heavy smokers undergoing a lung cancer screening program: a randomized controlled study. clinicaltrials.gov/show/NCT02422914 (accessed 17 February 2016). [CRS: 9400131000005080;]
100. NCT01842828 E-Cigarettes as an addition to multi-component treatment for tobacco dependence: a pilot study.. clinicaltrials.gov/show/NCT01842828 (accessed 16 July 2014)..
101. NCT01989923 Immediate smoking cessation for patients at risk for cervical dysplasia, cervical cancer and lower genital tract dysplasia and cancer - a feasibility study comparing nicotine replacement therapy with the electronic nicotine delivery system. clinicaltrials.gov/show/NCT01989923 (accessed 16 July 2014).
102. NCT02004171 Electronic nicotine delivery devices (ENDDs) or nicotine inhaler for smoking cessation. clinicaltrials.gov/show/NCT02004171 (accessed 16 July 2014).
103. NCT02029196 A randomised, parallel group, multi-centre study to evaluate the safety profile of the ITG EVP G1 product. clinicaltrials.gov/show/NCT02029196 (accessed 16 July 2014).
104. NCT02124187 Smoking cessation and reduction in depression (SCARID). clinicaltrials.gov/show/NCT02124187 (accessed 16 July 2014).
105. NCT02143310 A multi-centre study to evaluate the safety of use of electronic vapour products for two years. clinicaltrials.gov/show/NCT02143310 (accessed 16 July 2014).
106. NCT02212041 Acceptability, patterns of use and safety of electronic cigarette in people with mental illness: a pilot study. clinicaltrials.gov/show/NCT02212041 (accessed 17 February 2016). [CRS: 9400131000005045;]
107. NCT02261363 A mixed method EMA assessment of cognition and behavior among new ENDS users: an observational cohort study. clinicaltrials.gov/show/NCT02261363 2014 (accessed 15 August 2016). [CRS: 9400131000005078;]
108. NCT02328794 Randomized clinical trial to reduce harm from tobacco. clinicaltrials.gov/show/NCT02357173 (accessed 17 February 2016).
109. NCT02357173 A trial of e-cigarettes: natural uptake, patterns and impact of use. clinicaltrials.gov/show/NCT02357173 (accessed 17 February 2016). [CRS: 9400131000005049;]
110. NCT02398487 Head-to-head comparison of personal vaporizers versus cigalike: prospective 6-month randomized control design study. clinicaltrials.gov/show/NCT02398487 (accessed 17 February 2016). [CRS: 9400131000005074;]
111. NCT02417467 Evaluating the efficacy of e-cigarette use for smoking cessation (E3) trial. clinicaltrials.gov/show/NCT02417467 (accessed 17 February 2016). [CRS: 9400131000005055;]
112. NCT02482233 A pilot randomized controlled clinical trial - "Electronic nicotine delivery device (e-cigarette) for perioperative smoking cessation in veterans". clinicaltrials.gov/show/NCT02482233 (accessed 17 February 2016). [CRS: 9400131000005062;]
113. NCT02487953 Electronic nicotine delivery systems (ENDS) as a smoking cessation treatment. clinicaltrials.gov/show/NCT02487953 (accessed 17 February 2016). [CRS: 9400131000005072;]
114. NCT02498145 Short term effects of electronic cigarettes in tobacco dependent adults. clinicaltrials.gov/show/NCT02498145 (accessed 17 February 2016). [CRS: 9400131000005051;]
115. NCT02521662 A randomised-controlled clinical trial to evaluate the effectiveness and safety of combining nicotine patches with e-cigarettes (with and without nicotine) plus behavioural support, on smoking abstinence. clinicaltrials.gov/show/NCT02521662 (accessed 17 February 2016). [CRS: 9400131000005047;]
116. NCT02527980 E-cigarettes: dynamic patterns of use and health effects. clinicaltrials.gov/show/NCT02527980 (accessed 17 February 2016). [CRS: 9400131000005064;]
117. NCT02590393 The role of nicotine and non-nicotine alkaloids in e-cigarette use and dependence. clinicaltrials.gov/show/NCT02590393 (accessed 17 February 2016). [CRS: 9400131000005059;]
118. NCT02628964 Assessing the use of electronic cigarettes (e-cigarettes) as a harm reduction strategy. clinicaltrials.gov/show/NCT02628964 (accessed 17 February 2016). [CRS: 9400131000005053;]
119. NCT02635620 Changes in lung function parameters, bronchial reactivity, state of health and smoking behaviour associated with changing from conventional smoking to electronic cigarettes. clinicaltrials.gov/show/NCT02635620 (accessed 17 February 2016). [CRS: 9400131000005057;]
120. NCT02648178 Evaluation of appeal and impact of e-cigarettes among chronic smokers with smoking-related cancers. clinicaltrials.gov/show/NCT02648178 (accessed 17 February 2016). [CRS: 9400131000005068;]
121. Agaku IT, King BA, Husten CG, Bunnell R, Ambrose BK, Hu SS, et al. Tobacco product use among adults - United States, 2012-2013. MMWR - Morbidity & Mortality Weekly Report 2014;63(25):542-7.
122. Action on Smoking and Health. Use of electronic cigarettes (vapourisers) among adults in Great Britain. www.ash.org.uk/files/documents/ASH_891.pdf (accessed 21 July 2016).
123. Ayers JW, Ribisl KM, Brownstein JS. Tracking the rise in popularity of electronic nicotine delivery systems (electronic cigarettes) using search query surveillance. American Journal of Preventive Medicine 2011;40(4):448-53.
124. Balfour D. The neurobiology of tobacco dependence: A preclinical perspective on the role of dopamine projections to the nucleus. Nicotine & Tobacco Research 2004;6(6):899-912.
125. Barbeau AM, Burda J, Siegel M. Perceived efficacy of e-cigarettes versus nicotine replacement therapy among successful e-cigarette users: a qualitative approach. Addiction Science & Clinical Practice 2013;8:5.
126. Barrett SP. The effects of nicotine, denicotinized tobacco, and nicotine-containing tobacco on cigarette craving, withdrawal, and self-administration in male and female smokers. Behavorial Pharmacology 2010;21(2):144-52.
127. Bein K, Leikauf GD. Acrolein - a pulmonary hazard. Molecular Nutrition & Food Research 2011;55(9):1342-60.
128. Cahill K, Lindson-Hawley N, Thomas K, Fanshawe TR, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews 2016, Issue 5. [DOI: 10.1002/14651858.CD006103.pub7]
129. Centers for Disease Control and Prevention. Notes from the field: electronic cigarette use among middle and high school students - United States, 2011-2012. MMWR - Morbidity and Mortality Weekly Report 2013;62(35):729-30.
130. Chen C, Zhuang YL, Zhu SH. E-cigarette design preference and smoking cessation: a U.S. population study. American Journal of Preventive Medicine 2016 [Epub ahead of print]. [DOI: 10.1016/j.amepre.2016.02.002]
131. Dawkins L, Turner J, Roberts A, Soar K. 'Vaping' profiles and preferences: an online survey of electronic cigarette users. Addiction 2013;108(6):1115-25.
132. Donny EC, Houtsmuller E, Stitzer ML. Smoking in the absence of nicotine: behavioral, subjective and physiological effects over 11 days. Addiction 2007;102(2):324-34.
133. Donny EC, Jones M. Prolonged exposure to denicotinized cigarettes with or without transdermal nicotine. Drug and Alcohol Dependence 2009;104(1-2):23-33.
134. Etter JF, Bullen C. Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction 2011;106(11):2017-28.
135. European Parliament and Council of the European Union. Directive 2014/40/EU of the European Parliament and of the Council of 3 April 2014 on the approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of tobacco and related products and repealing Directive 2001/37/EC. www.ncdlinks.org/pie-elibrary/reports-publications/?entryid43=35159&p=8 2014 (accessed 25th November 2014).
136. Fagerström KO, Hughes JR. Nicotine concentrations with concurrent use of cigarettes and nicotine replacement: a review. Nicotine & Tobacco Research 2004;4(Suppl 2):S73-9.
137. Farsalinos KE, Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Therapeutic Advances in Drug Safety 2014;5(2):67-86.
138. U.S. Food, Drug Administration. Deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act, as amended by the Family Smoking Prevention and Tobacco Control Act. www.fda.gov/TobaccoProducts/Labeling/RulesRegulationsGuidance/ucm394909.htm 2016 (accessed 21st July 2016).
139. Gallus S, Lugo A, Pacifici R, Pichini S, Colombo P, Garattini S, et al. E-Cigarette awareness, use, and harm perception in Italy: a national representative survey. Nicotine & Tobacco Research 2014; Vol. 16, issue 12:1541-8.
140. Goniewicz ML, Kuma T, Gawron M, Knysak J, Kosmider L. Nicotine levels in electronic cigarettes. Nicotine & Tobacco Research 2012;15(1):158-66.
141. Goniewicz M L, Hajek P, McRobbie H. Nicotine content of electronic cigarettes, its release in vapour and its consistency across batches: regulatory implications. Addiction 2014;109(3):500-7.
142. Grana R, Benowitz N, Glantz SA. E-cigarettes: a scientific review. Circulation 2014;129(19):1972-86.
143. Gualano MR, Passi S, Bert F, La Torre G, Scaioli G, Siliquini R. Electronic cigarettes: assessing the efficacy and the adverse effects through a systematic review of published studies. Journal of Public Health 2015;37(3):488-97.
144. Hagstrom K, Gannon D, Sobieraj D. Electronic cigarettes for smoking cessation. Connecticut Medicine 2014;78(7):435-9.
145. Hajek P, West R, Foulds J, Nilsson F, Burrows S, Meadow A. Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. Archives of Internal Medicine 1999;159(17):2033-8.
146. Hajek P, Etter J-F, Benowitz N, Eissenberg T, McRobbie H. Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit. Addiction 2014;109(11):1801-10.
147. Hajek P, Goniewicz ML, Phillips A, Myers Smith K, West O, McRobbie H. Nicotine intake from electronic cigarettes on initial use and after 4 weeks of regular use. Nicotine & Tobacco Research 2015;17(2):175-9.
148. Hajek P, McRobbie H, Bullen C. E-cigarettes and smoking cessation. Lancet Respiratory Medicine 2016;4(6):e23.
149. Harrell PT, Simmons VN, Correa JB, Padhya TA, Brandon TH. Electronic Nicotine Delivery Systems ("E-cigarettes") Review of Safety and Smoking Cessation Efficacy. Otolaryngology--Head and Neck Surgery 2014;151(3):381-93.
150. Herzog B. E cigs revolutionizing the tobacco industry. Convenience Store News 2013;49(9):94-6.
151. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
152. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
153. Hitchman SC, Brose LS, Brown J, Robson D, McNeill A. Associations between e-cigarette type, frequency of use, and quitting smoking: findings from a longitudinal online panel survey in Great Britain. Nicotine and Tobacco Research 2015;17(10):1187-94.
154. Hua M, Talbot P. Potential health effects of electronic cigarettes: A systematic review of case reports. Preventive Medicine Reports 2016;4:169-78.
155. Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 2004;99(1):29-38.
156. Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T. Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews 2014, Issue 1. [DOI: 10.1002/14651858.CD000031.pub4]
157. Jiang N, Chen J, Wang MP, McGhee SM, Kwong AC, Lai VW, et al. Electronic cigarette awareness and use among adults in Hong Kong. Addictive Behaviors 2016;52:34-8.
158. Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Respiratory Medicine 2016;4(2):116-28.
159. Khoudigian S, Devji T, Lytvyn L, Campbell K, Hopkins R, O'Reilly D. The efficacy and short-term effects of electronic cigarettes as a method for smoking cessation: a systematic review and a meta-analysis. International Journal of Public Health 2016;61(2):257-67.
160. Kralikova E, Kubatova S, Truneckova K, Kmetova A, Hajek P. The electronic cigarette: what proportion of smokers have tried it and how many use it regularly?. Addiction 2012;107(8):1528-9.
161. Lam C, West A. Are electronic nicotine delivery systems an effective smoking cessation tool?. Canadian Journal of Respiratory Therapy 2015;51(4):93-8.
162. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD001292.pub2]
163. Levin ED, Behm F, Carnahan E, LeClair R, Shipley R, Rose JE. Clinical trials using ascorbic acid aerosol to aid smoking cessation. Drug and Alcohol Dependence 1993;33(3):211-23.
164. Malas M, Van der Tempel J, Schwartz R, Minichiello A, Lightfoot C, Noormohamed A, et al. Electronic cigarettes for smoking cessation: a systematic review. Nicotine & Tobacco Research 2016 [Epub ahead of print].
165. McKee M, Daube M, Chapman S. E-cigarettes should be regulated. Medical Journal of Australia 2016;204(9):331.
166. McNeill A, Brose LS, Calder R, Hitchman SC, Hajek P, McRobbie H. E-cigarettes: an evidence update. A report commissioned by Public Health England. www.gov.uk/government/uploads/system/uploads/attachment_data/file/457102/Ecigarettes_an_evidence:update_A_report_commissioned_by_Public_Health_England_FINAL.pdf 2015 (accessed 20th August 2016).
167. McRobbie H, Przulj D, Smith KM, Cornwall D. Complementing the standard multicomponent treatment for smokers with denicotinized cigarettes: a randomized trial. Nicotine & Tobacco Research 2016;18(5):1134-41.
168. Meo SA, Al Asiri SA. Effects of electronic cigarette smoking on human health. European Review for Medical and Pharmacological Sciences 2014;18(21):3315-9.
169. Orr KK, Asal NJ. Efficacy of electronic cigarettes for smoking cessation. Annals of Pharmacotherapy 2014;48(11):1502-6.
170. Palipudi KM, Mbulo L, Morton J, Bunnell R, Blutcher-Nelson G, Kosen S, et al. Awareness and current use of electronic cigarettes in Indonesia, Malaysia, Qatar, and Greece: findings From 2011-2013 global adult tobacco surveys. Nicotine & Tobacco Research 2016;18(4):501-7.
171. Perkins KA, Karelitz JL, Conklin CA, Sayette MA, Giedgowd GE. Acute negative affect relief from smoking depends on the affect situation and measure but not on nicotine. Biological Psychology 2010;67(8):707-14.
172. Pickworth WB, Fant RV, Nelson RA, Rohrer MS, Henningfield JE. Pharmacodynamic effects of new de-nicotinized cigarettes. Nicotine & Tobacco Research 1999;1(4):357-64.
173. Pisinger C, Dossing M. A systematic review of health effects of electronic cigarettes. Preventive Medicine 2014;69:248-60.
174. Przulj D, McRobbie H, Hajek P. The effect of sensorimotor replacement on smoking cessation and craving. Open Addiction Journal 2013;5:41-50.
175. Rahman MA, Hann N, Wilson A, Mnatzaganian G, Worrall-Carter L. E-cigarettes and smoking cessation: evidence from a systematic review and meta-analysis. PLoS ONE 2015;10(3):e0122544.
176. Rahman A, Nik Mohamed MH, Jamshed SQ. Safety and effectiveness of electronic cigarettes: A narrative review. International Medical Journal of Malaysia 2015;22(3):122-31.
177. Tobacco Advisory Group of the Royal College of Physicians. Nicotine Without Smoke-Tobacco Harm Reduction. London: Royal College of Physicians, 2016.
178. Rose JE, Tashkin DP, Ertle A, Zinser MC, Lafer R. Sensory blockade of smoking satisfaction. Pharmacology Biochemistry & Behavior 1985;23(2):289-93.
179. Rose JE, Behm FM, Levin ED. Role of nicotine dose and sensory cues in the regulation of smoke intake. Pharmacology Biochemistry & Behavior 1993;44(4):891-900.
180. Rose JE, Behm FM. Inhalation of vapor from black pepper extract reduces smoking withdrawal symptoms. Drug and Alcohol Dependence 1994;34(3):225-9.
181. Rose JE, Behm FM, Westman EC, Johnson M. Dissociating nicotine and nonnicotine components of cigarette smoking. Pharmacology Biochemistry & Behavior 2000;67(1):71-81.
182. Rose JE. Nicotine and nonnicotine factors in cigarette addiction. Psychopharmacology 2006;184(3-4):274-85.
183. Russell MAH. Nicotine intake and its control over smoking. In: Wonnacott S, Russell MAH, Stolerman I editor(s). Nicotine Psychopharmacology: Molecular, Cellular and Behavioural Aspects. London: Oxford University Press, 1990:374-418.
184. Schneider NG, Olmstead RE, Franzon MA, Lunell E. The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments. Clinical Pharmcokinetics 2001;40(9):661-84.
185. Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD001007.pub2]
186. Stead LF, Lancaster T. Nicobrevin for smoking cessation. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD005990]
187. Stead LF, Lancaster T. Interventions to reduce harm from continued tobacco use. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD005231.pub2]
188. Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews 2012, Issue 11. [DOI: 10.1002/14651858.CD000146.pub4]
189. Waghel RC, Battise DM, Ducker ML. Effectiveness of electronic cigarettes as a tool for smoking cessation or reduction. Journal of Pharmacy Technology 2015;31(1):8-12.
190. Walker N, Howe C, Bullen C, Grigg M, Glover M, McRobbie H, et al. The combined effect of very low nicotine content cigarettes, used as an adjunct to usual Quitline care (nicotine replacement therapy and behavioural support), on smoking cessation: a randomized controlled trial. Addiction 2012;107(10):1857-67.
191. West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005;100(3):299-303.
192. West R, Zhou X. Is nicotine replacement therapy for smoking cessation effective in the "real world"? Findings from a prospective multinational cohort study. Thorax 2007;62(11):998-1002.
193. West R, Beard B, Brown J. Trends in electronic cigarette use in England: Smoking Toolkit Study. www.smokinginengland.info/latest-statistics 2016 (accessed 20 August 2016).
194. Westman EC, Behm FM, Rose JE. Airway sensory replacement combined with nicotine replacement for smoking cessation. A randomized, placebo-controlled trial using a citric acid inhaler. Chest 1995;107(5):1358-64.
195. Westman EC, Behm FM, Rose JE. Dissociating the nicotine and airway sensory effects of smoking. Pharmacology Biochemistry & Behavior 1996;53(2):309-15.
196. World Health Organization. Electronic nicotine delivery systems: Report prepared by WHO for the sixth session of the Conference of the Parties to the WHO Framework Convention on Tobacco Control. apps.who.int/gb/fctc/PDF/cop6/FCTC_COP6_10-en.pdf?ua=1 2014 (accessed 25 November 2014).
197. McRobbie H, Bullen C, Hajek P. Electronic cigarettes for smoking cessation and reduction. Cochrane Database of Systematic Reviews 2012, Issue 11. [DOI: 10.1002/14651858.CD010216]
198. McRobbie H, Bullen C, Hartmann-Boyce J, Hajek P. Electronic cigarettes for smoking cessation and reduction. Cochrane Database of Systematic Reviews 2014, Issue 12. [DOI: 10.1002/14651858.CD010216.pub2]